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Is alcohol consumption irrelevant to outcome
in anxiety and depression?
Boschloo and colleagues1 report that DSM-IV alcohol abuse is not
a risk factor for unfavourable outcome in depression and anxiety
disorders. This finding, which ostensibly conflicts with clinical
experience, could easily be misunderstood to imply that non-
dependent alcohol use is irrelevant in these disorders. We do
not believe this is a true finding of the study. The paper addresses
DSM-IV alcohol use disorder diagnosis at baseline as a risk
factor for poor outcome. It does not address continuing alcohol
abuse and its effects on depression and anxiety. Latest alcohol
consumption statistics show that a substantial proportion of the
population drink alcohol heavily. In England, the latest estimates
are that 26% of men and 17% of women over the age of 16 drink
at levels that are hazardous or harmful to health.2 Clearly, only a
small proportion of these receive a diagnosis of alcohol use
disorder and there is no reason to believe that the situation in
The Netherlands is radically different. It would be expected that
a significant proportion of the sample with no alcohol use
disorder diagnosis would be drinking alcohol at hazardous or
harmful levels. Alcohol use disorder is therefore a poor marker
for alcohol consumption. Alcohol use disorder diagnosis cannot
have an effect on the course of depressive or anxiety disorders
as it is a theoretical construct. It is alcohol consumption that
has an effect. The current data are extracted from a larger study
with different aims3,4 and contain a number of flaws when used
to examine the effects of alcohol on depression and anxiety. There
are no indications of levels of alcohol consumption other than
alcohol use disorder diagnosis and there are no data on alcohol
diagnosis at follow-up. There is no information about what
treatments the sample patients received, although this is likely
to have included advice to reduce alcohol consumption.
Unsurprisingly, the study demonstrates that those with the
poorest depression and anxiety outcomes are those with a baseline
diagnosis of alcohol dependence, with a stronger effect with
increasing severity of disorder. That is, those patients least likely
to have reduced their alcohol consumption during the study
had the poorest outcomes. There is a puzzling finding in relation
to severity of alcohol diagnosis: there are more patients in the
sample with the more severe diagnosis of alcohol dependence than
with the less severe diagnosis of alcohol abuse. The diagnostic
criteria for alcohol abuse are concerned largely with social
dysfunction, whereas those for alcohol dependence are concerned
with physical dependence and social dysfunction. It may be that
the gap between the onset of moderate social dysfunction and
the onset of physical dependence or severe social dysfunction (as
determined by the diagnostic criteria) represents a small part of
the deterioration resulting from sustained heavy drinking, and
therefore is a poor indicator of population harmful drinking.
The paper does convincingly suggest that severe alcohol
dependence at baseline is a risk factor for poor outcome in anxiety
and depression. It does not demonstrate that continued drinking
in other groups is irrelevant to outcome.
1 Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Veltman DJ,
Beekman ATF, et al. Alcohol use disorders and the course of depressive
and anxiety disorders. Br J Psychiatry 2012; 200: 476–84.
2 Health and Social Care Information Centre. Statistics on Alcohol: England,
2012. Health and Social Care Information Centre, 2012.
3 Penninx BWJH, Beekman ATF, Smit JH, Zitman FG, Nolen WA, Spinhoven P,
et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale,
objectives and methods. Int J Methods Psychiatr Res 2008; 17: 121–40.
4 Van Der Veen WJ, Van Der Meer K, Penninx BW. Screening for depression
and anxiety: correlates of non-response and cohort attrition in the
Netherlands Study of Depression and Anxiety (NESDA). Int J Methods
Psychiatr Res 2009; 18: 229–39.
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Authors’ reply: We appreciate Bailey et al’s interest in our
study1 and respond to their comments regarding the found
differential effects of alcohol dependence v. alcohol abuse and
alcohol consumption.
It is evident that heavy alcohol consumption has a major
impact on public health because of its negative consequences on
the onset and course of various diseases.2 However, this does
not necessarily imply that the level of alcohol consumption is also
causally related to the onset and persistence of psychopathology
such as depression and anxiety. For example, Haynes et al3 showed
that heavy alcohol consumption was not a risk factor for the onset
of depression and anxiety in a national sample of adults in Great
Britain. Furthermore, additional analyses in our sample showed
that neither heavy alcohol consumption at baseline (odds ratio
(OR)= 0.98, 95% CI 0.71–1.36) nor at 2-year follow-up
(OR=0.98, 95% CI 0.69–1.41) predicted the persistence of
depression and anxiety.
In contrast, DSM-IV alcohol dependence has strong links with
depression and anxiety. For example, previous epidemiological
studies have demonstrated robust cross-sectional associations4,5
and, in addition, our study showed that alcohol dependence at
baseline was an important risk factor for the persistence of
depression and anxiety during 2-year follow-up (OR= 1.69, 95%
CI 1.04–2.75, adjusted for basic covariates).1 Additional analyses
further showed that this association remained significant after
controlling for the possible effects of alcohol consumption
(OR= 2.05, 95% CI 1.19–3.53, additionally adjusted for alcohol
consumption). This indicates that impairments related to alcohol
dependence, rather than consumption per se, have an effect on the
course of depression and anxiety. Support for this hypothesis was
also provided by our finding that persistence rates of depression
and anxiety increased with the severity of alcohol dependence
(i.e. number of alcohol dependence criteria).1
Previous studies have raised the question whether DSM-IV
alcohol abuse should be considered a genuine psychiatric disorder
as it was characterised by low severity in the general population
and showed limited reliability and validity (see Boschloo et al1
for a discussion on this topic). This notion received further
support by our finding that 95.7% of patients with alcohol abuse
met only one of four abuse criteria.1 Additional analyses showed
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that alcohol abuse was not related to impairments in daily
functioning (assessed with the World Health Organization
Disability Assessment Schedule II) and had a favourable course
(remission rate after 2 years: 93.5%). Apparently, alcohol abuse
is characterised by only minimal alcohol-related impairments,
which may clarify our finding that it was not related to the
persistence of depression and anxiety. Note that alcohol abuse in
our sample of out-patients with depression or anxiety or in the
general population might differ substantially from alcohol abuse
in clinical samples of severe abusers with regard to associated
levels of impairment.
Taken together, these findings emphasise the importance of
severity indicators, rather than dichotomous diagnoses of alcohol
dependence or abuse, in the assessment of alcohol problems. This
is in line with the proposal of the DSM-5 Work Group to
distinguish different levels of severity within the diagnosis of an
alcohol use disorder (www.dsm5.org).
1 Boschloo L, Vogelzangs N, Van den Brink W, Smit JH, Veltman DJ,
Beekman ATF, et al. Alcohol use disorders and the course of depressive
and anxiety disorders. Br J Psychiatry 2012; 200: 476–84.
2 World Health Organization. Global Status Report on Alcohol and Health. WHO,
2011.
3 Haynes JC, Farrell M, Singleton N, Meltzer H, Araya R, Lewis G, Wiles NJ.
Alcohol consumption as a risk factor for anxiety and depression. Results
from the longitudinal follow-up of the National Psychiatric Morbidity Survey.
Br J Psychiatry 2005; 187: 544–51.
4 Boschloo L, Vogelzangs N, Smit JH, Van den Brink W, Veltman DJ,
Beekman AT, et al. Comorbidity and risk indicators for alcohol use
disorders among persons with anxiety and/or depressive disorders:
findings from the Netherlands Study of Depression and Anxiety (NESDA).
J Affect Disord 2011; 131: 233–42.
5 Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability,
and comorbidity of DSM-IV alcohol abuse and dependence in the United
States: results from the National Epidemiologic Survey on Alcohol and
Related Conditions. Arch Gen Psychiatry 2007; 64: 830–42.
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Depression in the workplace: what is depression?
As a former consultant occupational psychiatrist to the
Metropolitan Police and a contributor to the Black & Frost
report,1 I would like to point to the basic flaw in the paper by
Gilbody et al.2
In Gilbody et al’s account of ‘depression in the workplace’, they
take ‘depression’ as a given, requiring no further explanation,
yet there is currently no psychiatric category so bloated and
subject to overdiagnosis. My experience of 900 assessments of
individuals at the Metropolitan Police, 99% of whom were
certificated as being ‘off sick’ with depression or one of the other
‘common mental disorders’, showed that the psychiatrisation of
non-specific symptoms led routinely to unduly prolonged sickness
absence and thus unnecessary disability.3 Sickness absence was
strongly associated with workplace problems and other situational
stresses: dislocation to a psychiatric arena frequently paralysed the
practical problem-solving that would have normalised the situa-
tion in timely fashion. I found that National Health Service
(NHS) mental health services were disconnected from the occupa-
tional aspects of patients’ lives, and saw diagnosis and treatment as
having a life of its own. Antidepressants and periodic out-patient
appointments did not seem a model that got many people back to
work. Naturally, I support Gilbody et al’s advocacy of closer
relations with the workplace but NHS services will continue to
be as much part of the problem as of the solution without a review
of the narrowly biomedical culture of much psychiatric practice.
Last, Gilbody et al see hope in the Layard Improving Access to
Psychological Therapies (IAPT) programme. It is laughable hubris
for the profession to imagine that large numbers of very hetero-
geneous people, many of whom have been out of the workplace
for years, can be gathered together under the rubric of ‘common
mental disorder’ and restored to full productivity via a few
sessions of talk therapy.
1 Black C, Frost D. Health at Work – An Independent Review of Sickness
Absence. TSO (The Stationery Office), 2011.
2 Gilbody S, Bower P, Rick J. Better care for depression in the workplace:
integrating occupational and mental health services. Br J Psychiatry 2012;
200: 442–3.
3 Summerfield D. Metropolitan Police blues: protracted sickness absence, ill
health retirement, and the occupational psychiatrist. BMJ 2011; 342: 950–2.
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Severe mental illness in prisoners worldwide
We read with interest the review article by Fazel & Seewald.1 The
authors conclude that severe mental illness is more prevalent in
prisoners in low- and middle-income (LAMI) countries than in
high-income countries. This may be related to fewer opportunities
and services for diverting offenders to health services, a stronger
relationship between mental illness and criminality, and different
sociocutural factors (e.g. poorer legal representation for the
mentally ill in LAMI countries).
We examined in an earlier study the relationship between
mental illness and criminality in pre-trial reported Antillean
defendants in The Netherlands and The Netherlands Antilles.2
Defendants who are suspected to have a mental illness are
examined pre-trial by a psychiatrist or psychologist both in The
Netherlands and The Netherlands Antilles, before diversion to
mental health services takes place. We found no significant
difference in the prevalence of psychotic disorders among pre-trial
reported Antillean suspects in The Netherlands and The
Netherlands Antilles (14.4% v. 15.1%) and no significant
difference in the prevalence of defendants deemed unaccountable
due to a mental disorder (3.9% v. 4.0%). There was, however, a
much lower registered crime rate of Antilleans in The Netherlands
Antilles than The Netherlands (11 v. 113 offences per year per
1000 persons; P50.001) and a much higher rate of pre-trial
reports in The Netherlands Antilles than The Netherlands (74 v.
8 per 1000 Antillean defendants; P50.001). Antilleans living in
The Netherlands Antilles thus have a low crime rate and a high
pre-trial report rate when indicted of a crime compared with
Antilleans in The Netherlands, indicating that they are more
frequently suspected to have a mental illness.
This finding is in line with the earlier formulated rule of
thumb that the frequency of mental illness is higher in countries
with low crime rates.3,4 Indeed, the LAMI countries included in
Fazel & Seewald’s review have a combined prison population rate
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of 77 per 100 000, considerably less than the worldwide prison
population rate of 145 per 100 000.5 The higher prevalence of
severe mental illness in prisoners in LAMI countries may be
explained by lower rates of crime and imprisonment. If so, the
relationship between mental illness and crime is not stronger in
LAMI countries, but weaker in high-income countries.
1 Fazel S, Seewald K. Severe mental illness in 33 588 prisoners worldwide:
systematic review and meta-regression analysis. Br J Psychiatry 2012; 200:
364–73.
2 Vinkers DJ, Heytel FG, Matroos GM, Hermans KM, Hoek HW. Pre-trial
psychiatric reports on Antillean suspected offenders in the Netherlands and
on the Dutch Antilles. Tijdschr Psychiatr 2010; 52: 745–52.
3 Large M, Smith G, Swinson N, Shaw J, Nielssen O. Homicide due to mental
disorder in England and Wales over 50 years. Br J Psychiatry 2008; 193:
130–3.
4 Coid J. The epidemiology of abnormal homicide and murder followed by
suicide. Psychol Med 1983; 13: 855–6.
5 Walmsley R. World Prison Population List (Eighth Edition). International
Centre for Prison Studies, King’s College London School of Law, 2009.
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Negative childhood experiences and mental health: theoretical,
clinical and primary prevention implications. BJP, 200, 89–91.
Reference 5 should read: Kingdon D, Sharma T, Hart D, the
Schizophrenia Subgroup of The Royal College of Psychiatrists’
Changing Minds Campaign. What attitudes do psychiatrists hold
towards people with mental illness? Psychiatr Bull 2004; 28: 401–6.
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